Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ)
CNY 21.55
(-0.23%)
CNY 21.55
(-0.23%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 62.44 Million CNY | 283.96% |
| 2022 | 16.26 Million CNY | 108.33% |
| 2021 | 7.8 Million CNY | -20.42% |
| 2020 | 9.8 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | -100.0% |
| 2011 | 10 Million CNY | 0.0% |
| 2010 | 10 Million CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 37.21 Million CNY | -33.89% |
| 2024 Q2 | 68.94 Million CNY | -9.18% |
| 2024 Q1 | 75.9 Million CNY | 21.56% |
| 2023 FY | 62.44 Million CNY | 283.96% |
| 2023 Q3 | 37.16 Million CNY | -16.97% |
| 2023 Q1 | 39.74 Million CNY | 144.39% |
| 2023 Q4 | 62.44 Million CNY | 68.02% |
| 2023 Q2 | 44.76 Million CNY | 12.62% |
| 2022 Q1 | 6.37 Million CNY | -18.29% |
| 2022 FY | 16.26 Million CNY | 108.33% |
| 2022 Q4 | 16.26 Million CNY | -13.52% |
| 2022 Q3 | 18.8 Million CNY | 232.85% |
| 2022 Q2 | 5.65 Million CNY | -11.42% |
| 2021 Q3 | 6.31 Million CNY | -12.44% |
| 2021 Q4 | 7.8 Million CNY | 23.64% |
| 2021 Q2 | 7.21 Million CNY | -16.06% |
| 2021 Q1 | 8.59 Million CNY | -12.42% |
| 2021 FY | 7.8 Million CNY | -20.42% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 FY | 9.8 Million CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q4 | 9.8 Million CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2016 Q3 | - CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 FY | - CNY | -100.0% |
| 2011 FY | 10 Million CNY | 0.0% |
| 2010 FY | 10 Million CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 2.54 Billion CNY | 97.545% |
| Zhejiang Zhenyuan Share Co., Ltd. | 138.12 Million CNY | 54.794% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 593.88 Million CNY | 89.486% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 935.85 Million CNY | 93.328% |
| Yifan Pharmaceutical Co., Ltd. | 1.99 Billion CNY | 96.87% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 4.36 Million CNY | -1330.307% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 7.55 Billion CNY | 99.174% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 273.99 Million CNY | 77.21% |
| Boai NKY Medical Holdings Ltd. | 60.4 Million CNY | -3.369% |